Attention-Deficit/Hyperactivity Disorder (ADHD) is frequently comorbid with other psychiatric disorders and also with somatic conditions, such as obesity. In addition to the clinical overlap, significant genetic correlations have been found between ADHD and obesity as well as body mass index (BMI). The biological mechanisms driving this association are largely unknown, but some candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the link between ADHD and obesity measures. Using the largest GWAS summary statistics currently available for ADHD (N=53,293), BMI (N=681,275), and obesity (N=98,697), we first tested the association of dopaminergic and circadian rhythm gene sets with each phenotype. This hypothesisdriven approach showed that the dopaminergic gene set was associated with both ADHD (P=5.81x10 -3 ) and BMI (P=1.63x10 -5 ), while the circadian rhythm gene set was associated with BMI only (P=1.28x10 -3 ). We then took a data-driven approach by conducting genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. This approach further supported the implication of dopaminergic signaling in the link between ADHD and obesity measures, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was significantly enriched in both the ADHD-BMI and ADHD-obesity gene-based meta-analysis results. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering the shared etiological factors underlying the frequently observed ADHDobesity comorbidity may have important implications in terms of preventive interventions and/or efficient treatment of these conditions.
INTRODUCTION
Attention-deficit/hyperactivity disorder (ADHD) is a psychiatric disorder characterized by developmentally inappropriate and impairing levels of inattention and/or hyperactivity and impulsivity symptoms. The prevalence of ADHD is estimated as 5.3% during childhood/adolescence 1 and around 2.8% during adulthood 2 . ADHD is among the most heritable psychiatric disorders, with heritability estimates around 74% 3 . It follows a multifactorial pattern of inheritance, where multiple genetic and environmental factors, each of small effect, as well as their interplay, can contribute to its pathophysiology. A recent genome-wide association study (GWAS) meta-analysis identified the first genome-significant associations for ADHD 4 .
High comorbidity rates are a hallmark of ADHD, further increasing disease burden. These comorbidities include both psychiatric 5, 6 and non-psychiatric (somatic) diseases and traits. One of the most frequently and consistently reported comorbid somatic conditions in ADHD is obesity 7 . Obesity is nowadays one of the major health problems worldwide, resulting in a large economic burden and significant decrease in life expectancy 8 , and its prevalence keeps rising substantially 9, 10 . Obesity is usually classified according to body mass index (BMI), which is calculated as weight in kilograms divided by the height in meters squared (kg/m 2 ). A BMI higher than 25 kg/m 2 signals overweight and a BMI above 30 kg/m 2 is regarded as obesity, which can be further subdivided into classes defined based on increasing BMI 11 . The genetic contribution to obesity and related phenotypes has been extensively studied, and heritability estimates range from 50% up to 90% 12 . Several GWASs have been conducted on obesity and BMI. For BMI, the most recent GWAS meta-analysis was performed in a sample of nearly 700,000 individuals and identified 536 associated genomic loci 13 . A previous GWAS on 158,864 participants with BMI information compared normal weight individuals to those with obesity classes I, II, and III 14 . The authors of this study concluded that associations found with the categorical phenotypes are highly overlapping with the ones obtained by using BMI as a quantitative trait 14 .
The prevalence of ADHD among adults seeking weight loss treatment for obesity has been reported to be around 27%, reaching up to 43% when considering only those with extreme obesity (i.e. class III) 15, 16 . This rate is more than ten times higher than the prevalence of ADHD in adults in the general population 2 .
Likewise, two recent meta-analyses show a higher than expected prevalence of overweight and/or obesity in individuals with ADHD, both during childhood/adolescence and adulthood, with odds ratios up to 1.55 and the strongest effects being observed in adults 17, 18 . Importantly, the association between ADHD and obesity was no longer significant when the analysis was limited to participants receiving pharmacological treatment for ADHD 17 .
The specific factors underlying the comorbidity between ADHD and obesity remain largely unknown.
Recently, significant genetic correlations between ADHD and BMI (rg=0. 21-0.26, 4, 19 , as well as between ADHD and obesity (ranging from rg=0.285 to rg=0.338, according to the different obesity classes) and other obesity-related phenotypes, have been reported 4 . These findings highlight the involvement of genetic factors in the observed epidemiological overlap between ADHD and obesity measures and provide an entry point for the investigation of the specific biological mechanisms and processes involved. Some candidate biological processes have been suggested, including dopaminergic neurotransmission and circadian rhythm signaling. These two candidate mechanisms have been selected as the main focus of a large European Union consortium aimed at studying comorbid conditions of ADHD (CoCA; https://coca-project.eu/), of which this study is part.
Altered reward processing and impaired inhibitory control, key features of ADHD, are thought to be the outcome of dysregulated dopaminergic neurotransmission 20 . Studies in humans and animal models have also linked disturbances in dopaminergic neurotransmission and downstream processes to obesity 21, 22 . It has been suggested that overeating may represent an attempt of obese people to compensate for their reduced sensitivity to rewards 21 .
Circadian rhythm-related traits (e.g. eveningness) and disturbances (e.g. sleep problems) have been repeatedly associated with ADHD and/or ADHD symptoms 23 . These problems have also been linked to BMI variation and obesity 24 . Disrupted circadian rhythm signaling may lead to obesity through temporal alterations in eating behavior and changes in metabolic hormones 25 . Two manifestations of circadian rhythm disruption in particular, sleeping problems (i.e. altered sleep duration) and an unstable eating pattern (e.g. skipping breakfast and binge eating later in the day), may mediate the observed association between ADHD symptoms and BMI 26 .
In this paper, we aimed to identify the shared etiological factors underlying the observed associations between ADHD and obesity measures. Specifically, we conducted (i) candidate gene-set association analyses and (ii) genome-wide gene-based cross-disorder(/trait) meta-analyses, followed by pathway enrichment analyses. Across our hypothesis-driven and data-driven analyses, we found altered dopaminergic signaling pathways to be implicated in ADHD and BMI/obesity.
MATERIALS AND METHODS

Participant samples
This study used summary statistics of ADHD, BMI, and obesity GWAS meta-analyses that have been made publicly available. These studies had been approved by local ethics committees and had obtained the required informed consents (as described in earlier publications 4, 13, 14 ).
The ADHD data was derived from 19,099 cases and 34, 194 For BMI, we used summary statistics from the most recent BMI GWAS meta-analysis that combined the earlier BMI summary statistics of the Genetic Investigation of ANthropometric Traits (GIANT) consortium 27 with new GWAS results from participants in the UK Biobank 13 . In total, this GIANT-UK Biobank BMI GWAS meta-analysis reached a mean sample size of N=681,275 participants of European ancestry 13 . After downloading the summary statistics from https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files, we filtered the data in order to include only SNPs with MAF >0.01 in our analyses, which yielded a total of 2,336,056
SNPs (see Yengo et al. 13 for further information on GWAS summary statistics quality control).
For obesity, summary statistics from a GWAS meta-analysis from European ancestry cohorts within the GIANT consortium on obesity class I were used 14 
ADHD -BMI genetic correlation analysis
Given the large sample increase of the most recent BMI GWAS, we conducted LD score regression analysis 28 to (re-)estimate the genetic correlation between ADHD and BMI using summary statistics of the largest GWAS currently available for each phenotype (samples described above). For this analysis, we used precomputed LD scores based on European samples from the 1000 Genomes Project as indicated in https://github.com/bulik/ldsc/wiki/Heritability-and-Genetic-Correlation.
Hypothesis-driven, candidate gene-set approach
Gene-set association analyses
In order to assess the links between the dopaminergic neurotransmission and circadian rhythm pathways and ADHD, BMI, and obesity, we assembled gene sets and tested their associations to the individual phenotypes of interest using the GWAS summary statistics described above. Dopaminergic Gene-set association analyses were performed using MAGMA software (version 1.05b 29 ). The first step was to carry out single gene-based analysis to assess the degree of association of each gene (i.e. gene-based Pvalues) with each phenotype. The second step was to test the association of each gene set, through competitive analyses, by aggregating the gene-based P-values according to their presence (or not) in the gene sets (see Supplementary Material for a more detailed description). We used a conservative Bonferroni correction to account for multiple testing by dividing the significance P-value threshold of 0.05 by the six gene-set tests that were performed (i.e. (DOPA, CIRCA) x ADHD, BMI, obesity) and hence, the gene-set significance P-value threshold was set to 8.33 x 10 -3 .
Data-driven, genome-wide approach
Gene-based cross-disorder/trait meta-analyses
In addition to the hypothesis-driven approach described above, we performed genome-wide gene-based cross-disorder(/trait) meta-analyses by using gene-based P-values for ADHD, BMI, and obesity (obtained as described above) and the gene meta-analysis option in MAGMA software (version 1.05b 29 ). The weighted
Stouffer's Z method was used to combine the Z-scores for each gene across cohorts, with weights set to the square root of the sample size each Z-score is based on (i.e. therefore accounting for the fact that sample sizes vary per SNP -and thus per gene -within and between GWAS summary statistics). Since we were interested in the combined effect of each gene on both phenotypes in each pair-wise meta-analysis (i.e. the ADHD-BMI or the ADHD-obesity meta-analyses), only genes present in both gene-based GWAS results were included. The gene-based P-value threshold for genome-wide significance was set to 0.05 divided by the number of genes in each gene-based meta-analysis.
Canonical pathway enrichment analyses
From each pair-wise gene-based cross-disorder(/trait) meta-analysis, we selected the genome-wide significant genes that increased significance by at least one order of magnitude compared to each of the original gene-based results (i.e. P meta-analysis < P ADHD /10 and P meta-analysis < P (obesity or BMI) /10). The set of genes meeting this criterion was then tested for enrichment of canonical pathways using Ingenuity Pathway Analysis (http://www.ingenuity.com; QIAGEN Bioinformatics, Redwood City, California, USA) set at its default parameters and using Benjamini-Hochberg correction for multiple testing (see Supplementary
Material for details).
RESULTS
ADHD-BMI genetic correlation
The ADHD-BMI genetic correlation was estimated as r g =0.3157 (SE=0.0246; P=8x10 -38 ). This is similar to estimates based on smaller BMI datasets as well as to estimates for the obesity classes previously reported 4, 19 and mentioned in the introduction.
DOPA and CIRCA gene-set associations with ADHD, BMI, and obesity
We tested the association of two gene sets -DOPA (264 genes) and CIRCA (284 genes) -with ADHD, BMI, and obesity. Results of these gene-set analyses are shown in Table 1 . The DOPA gene set was significantly associated with both ADHD (P=5.81x10 -3 ) and BMI (P=1.63x10 -5 ); the CIRCA gene set was only associated with BMI (P=1.28x10 -3 ). These results do not seem to be driven solely by one or very few individual genes that were highly associated with either ADHD or BMI ( Supplementary Table S1 ).
ADHD-BMI and ADHD-obesity gene-based meta-analyses
The gene-based cross-disorder(/trait) meta-analysis between ADHD and BMI resulted in 1684 genome-wide significant genes, while the one for ADHD and obesity resulted in 22 significant genes. Of those, 211 genes for the ADHD-BMI meta-analysis and 9 genes for the ADHD-obesity meta-analysis, showed an increase in their association significance (i.e. decrease in P-value) of at least one order of magnitude compared to both individual GWASs. These genes, which were all at least nominally significant in the original GWASs being meta-analyzed, are listed in Supplementary Tables S2 and S3 .
Canonical pathway enrichment analyses
Based on the 211 genes from our ADHD-BMI gene-based meta-analysis, the enrichment analysis identified four significant canonical pathways, as shown in Table 3) .
One pathway, the Dopamine-DARPP32 Feedback in cAMP Signaling, was found enriched in the two analyses. In total, proteins encoded by eight unique genes derived from our meta-analyses operate in this canonical pathway (Tables 2 and 3) . Combining the enrichment analysis with a literature search, we constructed a schematic representation of the Dopamine-DARPP32 Feedback in cAMP Signaling pathway, which is shown in Figure 1 and described in detail in the Supplementary Material.
In addition, a secondary ADHD-BMI gene-based cross-disorder(/trait) meta-analysis was carried out in order to address a small sample overlap between the datasets: Welcome Trust participants had been included both in the iPSYCH-PGC and the GIANT GWASs (for further information, see Supplementary Material). This resulted in 202 genes of interest, highly overlapping with the 211 genes from the main ADHD-BMI metaanalysis results (182 overlapping genes), where the Dopamine-DARPP32 Feedback in cAMP Signaling pathway remained significantly associated with the phenotype through the canonical pathway enrichment analysis.
DISCUSSION
In this paper, we aimed to uncover the biological mechanisms underlying the observed genetic associations between ADHD and obesity measures. Based on known and self-derived genetic correlation estimates for ADHD and BMI/obesity obtained from the world-wide largest datasets for each phenotype, we first applied a hypothesis-driven testing approach of two selected gene sets (DOPA and CIRCA), which showed that the dopaminergic neurotransmission system partially explains the genetic overlap between ADHD and BMI. Our data-driven, genome-wide approach subsequently showed that dopaminergic signaling, specifically
Dopamine-DARPP32 Feedback in cAMP Signaling, was significantly enriched in both the ADHD-BMI and the ADHD-obesity gene-based meta-analysis results.
Both ADHD and obesity measures have been linked to disturbances in dopaminergic signaling. Alterations of the brain's executive and reward circuits -modulated by mesocortical and mesolimbic dopamine, respectively -have been postulated as the basis of the deficient inhibitory control and impaired reward processing characteristics of ADHD 20 . The ability to resist the impulse to eat desirable foods, and an appropriate reward-response to those, also require proper functioning of these dopamine-regulated processes 21, 22 . For example, impulsive eating, as a result of a high arousal response to a potential reward and impaired inhibitory control, can lead to weight gain and obesity 30 . In addition, eating behavior is also dependent on the hypothalamic homeostatic system, which is comprised by hormonal regulators of energy balance -such as insulin, leptin, and gut hormones -and controls hunger, satiety, and adiposity levels 21 .
Increasing evidence suggests that such metabolic hormones can also affect food-related sensitivity of the dopaminergic reward system 31 , pointing to an overlap between the homeostatic and reward/reinforcement systems related to obesity 21 .
Also confirming our hypothesis, the CIRCA gene set was associated with BMI, but the absence of a significant association with ADHD was unexpected. ADHD has previously been associated with altered circadian rhythmicity at molecular, endocrine, and behavior levels 32 . Furthermore, mutations of a key gene in circadian rhythm regulation, per1b, in zebrafish have been shown to induce hyperactive, impulsivity-like, and attention deficit-like behaviors 33 . The lack of a significant association between ADHD and the CIRCA gene set in our study may be due to a true lack of effect of the circadian rhythm pathway on ADHD.
However, it is also possible that there is a true (unobserved) effect but that the gene set we assembled was not appropriate/informative enough to detect such association.
Going beyond candidate gene-set analyses, we conducted data-driven, genome-wide gene-based crossdisorder(/trait) meta-analyses to identify biological pathways underlying the shared heritability. Several pathways showed significant enrichment in the ADHD-BMI and in the ADHD-obesity results. Dopamine signaling was, again, at the heart of the pathway that was significantly enriched in both analyses, i.e. the DARPP-32 is highly expressed in postsynaptic dopaminergic neurons in the dorsal striatum (i.e. caudate and putamen), which is involved in certain executive functions, such as inhibitory control, and in the ventral striatum (i.e. nucleus accumbens), which is the main brain region responsible for reward processing (https://gtexportal.org/home/gene/PPP1R1B). As described above, poor inhibitory control and altered reward processing, in the form of steeper delay discounting, are key neurobiological circuitries implicated in both ADHD and obesity 20, 21 . Further evidence linking dopamine-DARPP-32 signaling, reward processing and the brain comes from findings in animal models. Upon investigation of the consequences of frustrated expected reward of palatable food on gene expression in the mouse brain, Dopamine-DARPP32 Feedback in cAMP Signaling pathway was found to be enriched among differentially expressed genes, both the ventral striatum and in frontal cortex 34 .
DARPP-32 modulates the effects of dopamine on cAMP/PKA-dependent gene transcription through transcription factors of the cyclic AMP-responsive element-binding (CREB) complex (Figure 1) , and CREB dysregulation has been linked to both ADHD 35 and obesity 36 . Of note, the CREB Signaling in Neurons pathway was also significantly enriched in our ADHD-BMI gene-based meta-analysis, along with two other partially overlapping pathways involved in synaptic plasticity processes (namely, the Synaptic Long Term Depression and the Synaptic Long Term Potentiation pathways; Table 2 ), which are also closely related to dopamine DARPP-32 signaling.
Additional evidence for an involvement of DARPP-32 signaling to the ADHD-BMI/obesity overlap comes from the study of rare variants. The most common form of monogenic obesity is caused by mutations in the melanocortin 4 receptor (MC4R) gene 37 and MRC4 signaling is known to activate DARPP-32 38 . In addition to early-onset obesity, a higher prevalence of ADHD has been reported in MC4R mutation-carriers 39 . It has been hypothesized that such co-occurrence may be, in part, underpinned by reward processing deficits 40 ,
and animal studies provide further support regarding the involvement of MC4R signaling and dopaminergic-dependent reward processing 38, 41 .
Our study has strengths and limitations. A clear strength is that we make use of the largest GWAS metaanalysis results available for each of the phenotypes being investigated. The sample sizes used to generate the (European ancestry) summary statistics used here were, in total, more than 53,000 for the iPSYCH-PGC ADHD GWAS, up to 700,000 for the GIANT-UK Biobank BMI GWAS, and almost 99,000 for the GIANT obesity GWAS. Another strength is that we did not restrict our gene set assembly to single GO-terms or KEGG pathways, but applied a more inclusive approach regarding the processes involved. For dopaminergic neurotransmission, we thus assembled a gene set (DOPA) that was subsequently found to be significantly associated with ADHD and BMI. This contrasts with the approach adopted in the iPSYCH-PGC ADHD GWAS paper, which tested dopaminergic candidate genes and GO-term pathways only individually, failing to detect significant associations with ADHD 4 . The large difference in sample sizes between the phenotypes imposed some difficulties when analyzing them together. We minimized such limitations by carrying out gene-based cross-disorder(/trait) meta-analyses in MAGMA, which allows sample sizes to vary between and within samples and accounts for such variation by weighting the effects accordingly. We also opted for performing gene-based -rather than SNP-based -cross-disorder(/trait) meta-analyses. Apart from assuming that the (combined effect of SNPs within) genes represent entities closer to the biological mechanisms, this approach has a reduced statistical burden compared to SNP-based analyses and seems most suitable for these data given the difference in SNP density between the ADHD and the BMI and obesity GWASs (the later ones being restricted to about 2.4 million SNPs present in HapMap 2). Another limitation we addressed was the presence of overlapping samples, since Welcome Trust participants had been included both in the iPSYCH-PGC ADHD GWAS and the GIANT BMI and obesity GWASs. The reduction in sample size reduced power of our analysis, but findings from the canonical pathway enrichment analysis remained stable.
Overall, the findings of the present study identify dopaminergic neurotransmission as a key player underlying the shared heritability of ADHD and BMI/obesity, implicating mechanisms involving DARPP-32 signaling in particular. This is especially interesting since DARPP-32 has been directly implicated in the mechanism of action of ADHD medication 42, 43 , which has been suggested to attenuate the increased risk for obesity in people with ADHD 17 . Uncovering critical aspects of the shared etiology underlying the prevalent ADHD-obesity comorbidity may have important implications for clinical outcome, preventive interventions, and/or efficient treatment of these conditions.
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a. Genes from the ADHD-obesity gene-based meta-analysis results, only considering genome-wide significant genes (at P threshold =2.97x10 -6 ) with association P-values lower by at least one order of magnitude in the meta-analysis compared to the gene-based results of both ADHD and obesity individually. b. Also part of DOPA in the gene-set analysis. c. Also part of CIRCA in the gene-set analysis.
Figure 1. Schematic representation of the Dopamine-DARPP32 Feedback in cAMP
Signaling pathway. The proteins encoded by the eight genome-wide significant genes derived from the ADHD-BMI gene-based meta-analysis results ( Table 2 ) are contextualized and highlighted in red in the pathway. A detailed description of the pathway in provided in the Supplementary Material. For clarity and simplicity, additional proteins in the pathway are omitted. Protein groups or complexes are shown with double margins.
